NYMOX PHARMACEUTICAL CORPORATION Sales And Marketing Expense
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Sales And Marketing Expense of $0 for the 3-month period ending 2024-09-30, per its 6-K filed 2025-01-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2025-01-02
- NYMOX PHARMACEUTICAL CORPORATION sales and marketing expense for the quarter ending 2024-09-30 was $0.00.
- NYMOX PHARMACEUTICAL CORPORATION sales and marketing expense for the quarter ending 2023-09-30 was $0.00.
- NYMOX PHARMACEUTICAL CORPORATION sales and marketing expense for the quarter ending 2023-06-30 was $0.00.
- NYMOX PHARMACEUTICAL CORPORATION sales and marketing expense for the quarter ending 2022-09-30 was $0.00.
| Period end | Sales And Marketing Expense 3 month | Sales And Marketing Expense 6 month | Sales And Marketing Expense 9 month | Sales And Marketing Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 6-K · filed 2025-01-02 | $0.00 6-K · filed 2025-01-02 | ||
| 2023-09-30 | $0.00 6-K · filed 2025-01-02 | $0.00 derived: sum of 2 quarters · filed 2025-01-02 | $0.00 6-K · filed 2025-01-02 | |
| 2023-06-30 | $0.00 6-K · filed 2023-08-14 | $0.00 6-K · filed 2023-08-14 | ||
| 2022-09-30 | $0.00 6-K · filed 2023-11-15 | $0.00 derived: sum of 2 quarters · filed 2023-11-15 | $0.00 6-K · filed 2023-11-15 | |
| 2022-06-30 | $0.00 6-K · filed 2023-08-14 | $0.00 6-K · filed 2023-08-14 | ||
| 2021-09-30 | $0.00 6-K/A · filed 2022-11-16 | $0.00 derived: sum of 2 quarters · filed 2022-11-16 | $0.00 6-K/A · filed 2022-11-16 | |
| 2021-06-30 | $0.00 6-K · filed 2022-08-15 | $0.00 6-K · filed 2022-08-15 | ||
| 2020-09-30 | $0.00 6-K · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 6-K · filed 2020-11-13 | |
| 2020-06-30 | $0.00 6-K · filed 2020-08-14 | $0.00 6-K · filed 2020-08-14 | ||
| 2019-09-30 | $0.00 6-K · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 6-K · filed 2020-11-13 | |
| 2019-06-30 | $0.00 6-K · filed 2020-08-14 | $0.00 6-K · filed 2020-08-14 | ||
| 2017-12-31 | $8.00K 20-F · filed 2020-03-30 | |||
| 2016-12-31 | $7.00K 20-F · filed 2019-03-29 | |||
| 2015-12-31 | $10.00K 20-F · filed 2018-03-30 |